Systemic Anti-Cancer Therapy Regimen Library
Terms of Use, Guidance and Disclaimers
The SACT Regimen Library is published by the NZ Formulary on behalf of Te Aho o Te Kahu. The NZF standard terms will apply to website users
Guidance
The SACT medicines, doses, combinations, and schedules in this treatment regimen (the information) have been carefully reviewed against international best practice guidelines by specialists in medical oncology and haematology around New Zealand and this advice has been accepted for publication by Te Aho o Te Kahu (the Cancer Control Agency).
The information is not intended to replicate or replace the knowledge, skills and experience of trained oncology health professionals, nor is it a substitute for clinical judgement and advice. Clinicians should exercise professional judgement in evaluating the information, and are encouraged to confirm the information with other sources before undertaking any treatment based on it.
Cancer clinicians are advised that this application describes cancer treatment information only, and is not a clinical oncology management information system, a drug prescribing system, or a clinical decision support system.
Sometimes medicines that are used in routine clinical practice have not been through a formal review process by the NZ Medicines Regulator Medsafe at the time of prescription, and are therefore considered unapproved or off-label. These medicines are legally able to be prescribed provided sections 25 and 29 of the Medicines Act are complied with, and by obtaining informed consent from patients. All treatment regimens listed on this website have been through robust peer review and are considered an accepted standard of care, whether prescribed through sections 25 or 29 or carrying formal Medsafe Approval.
Best endeavours will be applied to maintain the most current SACT regimens on the NZF. Clinicians must check for the latest SACT regimen prior to prescribing any regimen.
Elements of these regimen definitions are intentionally non-specific to reflect that they may vary between institutions and to allow for these local preferences. It is incumbent on any institution to ensure the safety of any customisations and their clinical appropriateness for individual patients (eg, consideration of patient comorbidities).
Disclaimer
The Information contained on this website is intended to provide guidance only. While care has been undertaken to describe and include the most appropriate cancer treatment protocols in the information, Te Aho o Te Kahu (the Cancer Control Agency), the Ministry of Health and the contributors to the information (the Parties) have no liability for any consequences of applying the cancer therapy guidelines set out in the information, nor any errors of administration, or drug dose calculation.
The Parties have no responsibility for the accuracy, currency, completeness, reliability and correctness of any information included in the information provided.
Links to other Internet sites are provided for information only. Although care has been taken in providing these links as suitable reference resources, due to the changing nature of internet content, it is the responsibility of the users to make their own investigations, decisions and enquiries about the information retrieved from other internet sites. Provision of these links does not imply any endorsement, non-endorsement, or support of the Parties.
The information is developed solely for the New Zealand jurisdiction, and there is no warranty that the content of the website complies with law of any other country.
Each SACT Regimen to which s25 or s29 of the Medicines act applies will have this specific disclaimer included as part of each Regimen Medicines that have not been through a formal review process by the NZ Medicines Regulator, Medsafe, at the time of prescription, are considered unapproved or off-label. These medicines are legally able to be prescribed provided sections 25 and 29 of the Medicines Act are complied with, and by obtaining informed consent from patients. Each clinician will retain full responsibility for ensuring he or she has complied with all relevant obligations and requirements of sections 25 and 29 prior to prescribing the applicable SACT-NZ Regimen.
HomeFAQGlossaryWhat's newSubscribe to monthly update